Listed

GENELUX Corp

GNLXNasdaqCIK 1231457HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2024
Operating income−$9.6m, Q2 FY2026
Net income−$9.5m, Q2 FY2026
GENELUX Corp, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001493152-24-045790. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-28, accession 0001641172-25-001184. Derived: 12-month figure less the 9-month figure.Report this figure8.0Revenue, Q1 FY2024, three months to 2024-03-31$8.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001641172-25-022583. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001493152-25-020874. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k2,819Research and development, Q3 FY2023, three months to 2023-09-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figure4,160Research and development, Q4 FY2023, three months to 2023-12-31$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-28, accession 0001641172-25-001184. Derived: 12-month figure less the 9-month figure.Report this figure4,010Research and development, Q1 FY2024, three months to 2024-03-31$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure4,417Research and development, Q2 FY2024, three months to 2024-06-30$4.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001641172-25-022583.Report this figure4,051Research and development, Q3 FY2024, three months to 2024-09-30$4.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure6,520Research and development, Q4 FY2024, three months to 2024-12-31$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figure4,698Research and development, Q1 FY2025, three months to 2025-03-31$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure4,758Research and development, Q2 FY2025, three months to 2025-06-30$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure4,741Research and development, Q3 FY2025, three months to 2025-09-30$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure5,654Research and development, Q4 FY2025, three months to 2025-12-31$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figure5,778Research and development, Q1 FY2026, three months to 2026-03-31$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure6,508Research and development, Q2 FY2026, three months to 2026-06-30$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure
Operating income$k(5,307)Operating income, Q3 FY2023, three months to 2023-09-30−$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figure(7,001)Operating income, Q4 FY2023, three months to 2023-12-31−$7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-28, accession 0001641172-25-001184. Derived: 12-month figure less the 9-month figure.Report this figure(8,115)Operating income, Q1 FY2024, three months to 2024-03-31−$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure(6,892)Operating income, Q2 FY2024, three months to 2024-06-30−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001641172-25-022583.Report this figure(6,941)Operating income, Q3 FY2024, three months to 2024-09-30−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure(9,748)Operating income, Q4 FY2024, three months to 2024-12-31−$9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figure(7,816)Operating income, Q1 FY2025, three months to 2025-03-31−$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure(7,792)Operating income, Q2 FY2025, three months to 2025-06-30−$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure(8,194)Operating income, Q3 FY2025, three months to 2025-09-30−$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure(9,412)Operating income, Q4 FY2025, three months to 2025-12-31−$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figure(9,171)Operating income, Q1 FY2026, three months to 2026-03-31−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure(9,645)Operating income, Q2 FY2026, three months to 2026-06-30−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure
Interest expense$knot reported6.0Interest expense, Q4 FY2023, three months to 2023-12-31$6.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-28, accession 0001641172-25-001184. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k(5,345)Net income, Q3 FY2023, three months to 2023-09-30−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figure(6,767)Net income, Q4 FY2023, three months to 2023-12-31−$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-28, accession 0001641172-25-001184. Derived: 12-month figure less the 9-month figure.Report this figure(7,850)Net income, Q1 FY2024, three months to 2024-03-31−$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure(6,576)Net income, Q2 FY2024, three months to 2024-06-30−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure(6,467)Net income, Q3 FY2024, three months to 2024-09-30−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure(8,976)Net income, Q4 FY2024, three months to 2024-12-31−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figure(7,492)Net income, Q1 FY2025, three months to 2025-03-31−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure(7,456)Net income, Q2 FY2025, three months to 2025-06-30−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure(7,950)Net income, Q3 FY2025, three months to 2025-09-30−$8.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure(9,247)Net income, Q4 FY2025, three months to 2025-12-31−$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figure(8,928)Net income, Q1 FY2026, three months to 2026-03-31−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure(9,471)Net income, Q2 FY2026, three months to 2026-06-30−$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure
Diluted EPS$ per share(0.20)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figurenot reported(0.29)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure(0.22)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001641172-25-022583.Report this figure(0.19)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure(0.20)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure(0.21)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure(0.21)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure
Basic EPS$ per share(0.20)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figurenot reported(0.29)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure(0.22)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001641172-25-022583.Report this figure(0.19)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figurenot reported(0.21)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure(0.20)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure(0.21)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figurenot reported(0.20)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure(0.21)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure

Balance sheet

Cash and equivalents$9.2m, Q2 FY2026
Shareholders' equity$16.1m, Q2 FY2026
GENELUX Corp, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m29.9Cash and equivalents, Q3 FY2023, at 2023-09-30$29.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001493152-23-041151.Report this figure9.4Cash and equivalents, FY2023, at 2023-12-31$9.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-28, accession 0001641172-25-001184.Report this figure4.1Cash and equivalents, Q1 FY2024, at 2024-03-31$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001493152-24-018436.Report this figure7.9Cash and equivalents, Q2 FY2024, at 2024-06-30$7.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001493152-24-032145.Report this figure6.1Cash and equivalents, Q3 FY2024, at 2024-09-30$6.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figure8.6Cash and equivalents, FY2024, at 2024-12-31$8.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001493152-26-011616.Report this figure16.2Cash and equivalents, Q1 FY2025, at 2025-03-31$16.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure6.5Cash and equivalents, Q2 FY2025, at 2025-06-30$6.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001641172-25-022583.Report this figurenot reported5.3Cash and equivalents, FY2025, at 2025-12-31$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure9.3Cash and equivalents, Q1 FY2026, at 2026-03-31$9.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure9.2Cash and equivalents, Q2 FY2026, at 2026-06-30$9.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure
Current assets$m31.2Current assets, Q3 FY2023, at 2023-09-30$31.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041151.Report this figure24.2Current assets, FY2023, at 2023-12-31$24.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-28, accession 0001641172-25-001184.Report this figure21.2Current assets, Q1 FY2024, at 2024-03-31$21.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001493152-24-018436.Report this figure34.9Current assets, Q2 FY2024, at 2024-06-30$34.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032145.Report this figure36.0Current assets, Q3 FY2024, at 2024-09-30$36.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figure31.5Current assets, FY2024, at 2024-12-31$31.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001493152-26-011616.Report this figure35.9Current assets, Q1 FY2025, at 2025-03-31$35.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure29.2Current assets, Q2 FY2025, at 2025-06-30$29.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001641172-25-022583.Report this figure21.6Current assets, Q3 FY2025, at 2025-09-30$21.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure15.1Current assets, FY2025, at 2025-12-31$15.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure26.8Current assets, Q1 FY2026, at 2026-03-31$26.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure19.1Current assets, Q2 FY2026, at 2026-06-30$19.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure
Total assets$m34.1Total assets, Q3 FY2023, at 2023-09-30$34.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001493152-23-041151.Report this figure27.9Total assets, FY2023, at 2023-12-31$27.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-28, accession 0001641172-25-001184.Report this figure24.7Total assets, Q1 FY2024, at 2024-03-31$24.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001493152-24-018436.Report this figure45.2Total assets, Q2 FY2024, at 2024-06-30$45.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001493152-24-032145.Report this figure40.3Total assets, Q3 FY2024, at 2024-09-30$40.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figure34.7Total assets, FY2024, at 2024-12-31$34.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001493152-26-011616.Report this figure39.0Total assets, Q1 FY2025, at 2025-03-31$39.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure32.2Total assets, Q2 FY2025, at 2025-06-30$32.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001641172-25-022583.Report this figure25.0Total assets, Q3 FY2025, at 2025-09-30$25.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure19.0Total assets, FY2025, at 2025-12-31$19.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure32.4Total assets, Q1 FY2026, at 2026-03-31$32.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure26.2Total assets, Q2 FY2026, at 2026-06-30$26.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure
Current liabilities$m8.8Current liabilities, Q3 FY2023, at 2023-09-30$8.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041151.Report this figure6.6Current liabilities, FY2023, at 2023-12-31$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-28, accession 0001641172-25-001184.Report this figure7.8Current liabilities, Q1 FY2024, at 2024-03-31$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001493152-24-018436.Report this figure5.8Current liabilities, Q2 FY2024, at 2024-06-30$5.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032145.Report this figure5.6Current liabilities, Q3 FY2024, at 2024-09-30$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figure6.9Current liabilities, FY2024, at 2024-12-31$6.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001493152-26-011616.Report this figure7.7Current liabilities, Q1 FY2025, at 2025-03-31$7.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure7.0Current liabilities, Q2 FY2025, at 2025-06-30$7.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001641172-25-022583.Report this figure5.1Current liabilities, Q3 FY2025, at 2025-09-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure6.2Current liabilities, FY2025, at 2025-12-31$6.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure7.3Current liabilities, Q1 FY2026, at 2026-03-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure8.0Current liabilities, Q2 FY2026, at 2026-06-30$8.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure
Total liabilities$m10.0Total liabilities, Q3 FY2023, at 2023-09-30$10.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001493152-23-041151.Report this figure8.4Total liabilities, FY2023, at 2023-12-31$8.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-28, accession 0001641172-25-001184.Report this figure9.6Total liabilities, Q1 FY2024, at 2024-03-31$9.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001493152-24-018436.Report this figure7.5Total liabilities, Q2 FY2024, at 2024-06-30$7.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001493152-24-032145.Report this figure7.2Total liabilities, Q3 FY2024, at 2024-09-30$7.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figure8.4Total liabilities, FY2024, at 2024-12-31$8.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001493152-26-011616.Report this figure9.1Total liabilities, Q1 FY2025, at 2025-03-31$9.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure8.3Total liabilities, Q2 FY2025, at 2025-06-30$8.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001641172-25-022583.Report this figure6.4Total liabilities, Q3 FY2025, at 2025-09-30$6.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure7.5Total liabilities, FY2025, at 2025-12-31$7.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure9.5Total liabilities, Q1 FY2026, at 2026-03-31$9.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure10.1Total liabilities, Q2 FY2026, at 2026-06-30$10.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure
Short-term borrowings$m0.9Short-term borrowings, Q3 FY2023, at 2023-09-30$900.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2023-11-14, accession 0001493152-23-041151.Report this figure0.9Short-term borrowings, FY2023, at 2023-12-31$900.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2025-03-28, accession 0001641172-25-001184.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m24.0Shareholders' equity, Q3 FY2023, at 2023-09-30$24.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figure19.5Shareholders' equity, FY2023, at 2023-12-31$19.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001493152-26-011616.Report this figure15.1Shareholders' equity, Q1 FY2024, at 2024-03-31$15.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure37.7Shareholders' equity, Q2 FY2024, at 2024-06-30$37.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure33.1Shareholders' equity, Q3 FY2024, at 2024-09-30$33.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure26.3Shareholders' equity, FY2024, at 2024-12-31$26.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure29.8Shareholders' equity, Q1 FY2025, at 2025-03-31$29.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure23.9Shareholders' equity, Q2 FY2025, at 2025-06-30$23.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure18.6Shareholders' equity, Q3 FY2025, at 2025-09-30$18.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure11.5Shareholders' equity, FY2025, at 2025-12-31$11.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure22.9Shareholders' equity, Q1 FY2026, at 2026-03-31$22.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure16.1Shareholders' equity, Q2 FY2026, at 2026-06-30$16.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure

Cash flow

Operating cash flow−$6.4m, Q2 FY2026
Capital expenditure$1.5m, Q2 FY2026
GENELUX Corp, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(3,357)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001493152-24-045790. Derived: 9-month figure less the 6-month figure.Report this figure(6,910)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-28, accession 0001641172-25-001184. Derived: 12-month figure less the 9-month figure.Report this figure(4,354)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure(6,824)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001641172-25-022583. Derived: 6-month figure less the 3-month figure.Report this figure(5,748)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001493152-25-020874. Derived: 9-month figure less the 6-month figure.Report this figure(4,302)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figure(5,435)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure(7,059)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037667. Derived: 6-month figure less the 3-month figure.Report this figure(6,575)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001493152-25-020874. Derived: 9-month figure less the 6-month figure.Report this figure(6,199)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figure(6,059)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure(6,444)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037667. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k277Capital expenditure, Q3 FY2023, three months to 2023-09-30$277.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001493152-24-045790. Derived: 9-month figure less the 6-month figure.Report this figure243Capital expenditure, Q4 FY2023, three months to 2023-12-31$243.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-28, accession 0001641172-25-001184. Derived: 12-month figure less the 9-month figure.Report this figure30.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$30.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure228Capital expenditure, Q2 FY2024, three months to 2024-06-30$228.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001641172-25-022583. Derived: 6-month figure less the 3-month figure.Report this figure27.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001493152-25-020874. Derived: 9-month figure less the 6-month figure.Report this figure96.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$96.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figure30.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$30.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure115Capital expenditure, Q2 FY2025, three months to 2025-06-30$115.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037667. Derived: 6-month figure less the 3-month figure.Report this figure517Capital expenditure, Q3 FY2025, three months to 2025-09-30$517.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001493152-25-020874. Derived: 9-month figure less the 6-month figure.Report this figure436Capital expenditure, Q4 FY2025, three months to 2025-12-31$436.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001493152-26-011616. Derived: 12-month figure less the 9-month figure.Report this figure921Capital expenditure, Q1 FY2026, three months to 2026-03-31$921.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure1,532Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037667. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)44.96m, Q2 FY2026
GENELUX Corp, shares, quarterly
Line itemUnitperiod not labelled2022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares10.1Diluted shares (weighted), period not labelled, three months to 2022-09-3010,073,788 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001493152-23-041151.Report this figure19.6Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3119,575,631 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001493152-24-018436.Report this figure25.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3025,068,334 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001493152-24-032145.Report this figure26.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3026,210,068 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001493152-24-045790.Report this figure26.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3126,849,737 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001641172-25-008838.Report this figure29.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3029,689,344 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001641172-25-022583.Report this figure34.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3034,532,355 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure34.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3134,926,075 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure37.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3037,946,330 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure37.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3037,893,314 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001493152-25-020874.Report this figure44.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3144,150,958 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001493152-26-021710.Report this figure45.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3044,959,426 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure

Shares outstanding: 45.25mShares outstanding, period not labelled, at 2026-08-1145,245,335 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037667.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.